Liver Disease Clinical Trials in Seattle, Washington
12 recruitingSeattle, Washington
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company4,500 enrolled561 locationsNCT07165028
Recruiting
Primary Sclerosing Cholangitis in Children
Liver DiseasesPrimary Sclerosing CholangitisCholangitis, Sclerosing
Arbor Research Collaborative for Health1,000 enrolled12 locationsNCT04181138
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc.1,350 enrolled349 locationsNCT06318169
Recruiting
Phase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Non-Alcoholic Fatty Liver Disease
GlaxoSmithKline1,200 enrolled49 locationsNCT07221227
Recruiting
Phase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-Alcoholic Fatty Liver Disease
GlaxoSmithKline1,250 enrolled43 locationsNCT07221188
Recruiting
Phase 2
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Alcohol Liver Disease
Altimmune, Inc.100 enrolled43 locationsNCT07009860
Recruiting
Not Applicable
Copper Supplementation in Cirrhosis
CirrhosisFibrosisInfection+1 more
University of Washington30 enrolled1 locationNCT07471542
Recruiting
Not Applicable
Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
NAFLD - Non-Alcoholic Fatty Liver DiseaseMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
ContextVision AB110 enrolled1 locationNCT07270601
Recruiting
Genetic Collection Protocol
Liver Diseases
Arbor Research Collaborative for Health2,230 enrolled13 locationsNCT05272319
Recruiting
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Pediatric ALLMalnutritionParenteral Nutrition Associated Liver Disease (PNALD)+1 more
Fresenius Kabi40 enrolled10 locationsNCT06274788
Recruiting
Functional Assessment in Liver Transplantation
End Stage Liver Disease
University of California, San Francisco5,000 enrolled12 locationsNCT03228290
Recruiting
Phase 2
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
Intestinal Failure-associated Liver Disease
NorthSea Therapeutics B.V.36 enrolled13 locationsNCT05919680